80% Chance FPRX Will Skyrocket on January 15th, 2021
Five Prime Therapeutics is developing a highly effective cancer treatment. Currently, they are on phase two of their clinical trials. When they released their phase one data on November tenth, the stock rose 200%+. On January 15, 2021, they will release phase two trial data. If the data is good, you could be looking at 50-100% gains.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.